6 生命科学、医疗保健、制药 职位 Beijing
Shanghai,Beijing, East China Permanent
发布于: 18/10/2026
Responsibilities: Execute target mining, target validation, and program initiation based on robust tumor biology and clinical insights to fulfill BeiGene drug discovery goals Support oncology drug discovery programs, including but not limited to small molecule drugs or antibody-drug conjugates (ADCs...
Shanghai,Beijing, East China Permanent
发布于: 09/10/2026
China NDA & Regulatory Support Serve as the key PV contact for China NDA-related activities. Support preparation, review, and response to NMPA/CDE safety-related questions and information requests during the NDA review process. Provide PV input to China regulatory submissions, safety documents, ri...
Shanghai,Beijing, East China Permanent
发布于: 20/09/2026
We are seeking an experienced scientist to drive novel target discovery through the development and application of AI Agents, bioinformatics, and biomedical data science. This role will build reusable Agent Skills, biomedical knowledge databases, and scalable analytical workflows, and will directly use these capab...
Shanghai,Beijing, East China Permanent
发布于: 13/09/2026
I. Job Responsibilities Clinical Development Strategy Formulation and Execution Develop global clinical development strategies for the company's innovative drugs in non-oncology therapeutic areas (with priority given to neurology or pain-related fields). Lead the desi...
Shanghai,Beijing, East China Permanent
发布于: 05/09/2026
Main responsibility: Support drug discovery projects at various stages from CADD perspective including but not limited to druggability evaluation, virtual screening, hit triage, rational design etc. Apply state-of-art computational methods including physics-based and data-driven approaches to the most...
Beijing, North China Permanent
发布于: 28/08/2026
汇报对象 :CEO / COO 工作地点 :北京 关于我们 我们的客户是一家AI原生生物科技公司。 股东结构含 中国大模型头部公司,产业方背书 上海国资背景,专注生物医药产业转化 头部美元VC – 多轮加注,资本价值验证 商业化已落地超20项BD合作。正处于从技术验证到商业化高速增长的拐点。 岗位职责: 核心三件事: 1. 主导融资 从策略制定、投资人触达、路演,到协议谈判、关账落地,全程操盘。目前机构主动找过来的很多,你需要判断谁该见、谁该推、怎么转化。 ...